Human blood platelet gC1qR/p33

Immunological Reviews

Volumn 180, Issue , 2001, Pages 56-64

  Peerschke, Ellinor I B ^a,c   Ghebrehiwet, Berhane ^b  

^a WEILL CORNELL MEDICAL COLLEGE   (United States)

^b STONY BROOK UNIVERSITY   (United States)

^c NEW YORK PRESBYTERIAN HOSPITAL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

COMPLEMENT COMPONENT C1Q;

ANTIGEN ANTIBODY COMPLEX; ATHEROSCLEROSIS; BINDING SITE; COMPLEX FORMATION; HEMOSTASIS; HUMAN; PRIORITY JOURNAL; REVIEW; THROMBOCYTE; THROMBOCYTE AGGREGATION; THROMBOSIS; VASCULITIS;

ANTIGENS, CD44; BACTERIAL ADHESION; BIOTINYLATION; BLOOD COAGULATION FACTORS; BLOOD PLATELETS; CARRIER PROTEINS; COMPLEMENT C1Q; HUMANS; KININS; LIGANDS; MEMBRANE GLYCOPROTEINS; MITOCHONDRIAL PROTEINS; PLATELET AGGREGATION; PROTEIN BINDING; RECEPTORS, COMPLEMENT; RECOMBINANT FUSION PROTEINS; STAPHYLOCOCCAL INFECTIONS; STAPHYLOCOCCAL PROTEIN A; STAPHYLOCOCCUS AUREUS; VIRULENCE;

EID: 0034996562     PISSN: 01052896     EISSN: None     Source Type: Journal    
DOI: 10.1034/j.1600-065X.2001.1800105.x     Document Type: Review

References (57)

1. 1. Calcott MA, Muller-Eberhard HJ. C1q protein of human complement. Biochemistry 1972;11:3443-3450.
2. 2. Reid KBM, Thompson RA. Characterization of non-functional form of C1q found in patients with genetically linked deficiency of C1q activity. Mol Immunol 1983;20:1117-1125.
3. 3. Reid KBM. Molecular cloning and characterization of the complementary DNA and gene coding for the B chain subcomponent C1q of the human complement system. Biochem J 1985;231:729-735.
4. 4. Muller-Eberhard HJ. Complement: molecular mechanisms, regulation and biologic function. In: Berlin RD, Herman H, Lepow I, Tanzer JM, eds. Molecular basis of biological degradative process. New York: Academic Press; 1978. p. 25-64.
5. 5. Ghebrehiwet B. Functions associated with the C1q receptor. Behring Inst Mitt 1989;84:204-215.
6. 6. Ghebrehiwet B, Silvestri L, McDevitt C. Identification of the Raji cell membrane-derived C1q inhibitor as a receptor for human C1q. Purification and immunochemical characterization. J Exp Med 1984;160:1375-1389.
7. 7. Malhotra R, Thiel S, Reid KBM, Sim RB. Human leukocyte C1q receptor binds other soluble proteins with collagen domains. J Exp Med 1990;172;955-959.
8. 8. Guan IE, Burgess WH, Robinson SL, Goodman EB, McTigue KJ, Tenner AJ. Phagocytic cell molecules that bind the collagen-like region of C1q. Involvement in the C1q-mediated enhancement of phagocytosis. J Biol Chem 1991;366:20345-20355.
9. 9. Klickstein LB, Barbashov SF, Lie T, Jack RM, Nicholson-Weller A. Complement receptor type 1 (CR1, CD35) is a receptor for C1q. Immunity 1997;7:345-355.
10. 10. Ghebrehiwet B, Lim BL, Peerschke EIB, Willis AC, Reid KBM. Isolation, cDNA cloning, and overexpression of a 33-kDa cell surface glycoprotein that binds to the globular 'heads' of C1q. J Exp Med 1994;179:1809-1821.
11. 11. Ghebrehiwet B, et al. Evidence that the two C1q-binding membrane proteins gC1q-R and cC1q-R associate to form a metal ion-independent complex. J Immunol 1997;159:1429-1436.
12. 12. Peerschke EIB, Ghebrehiwet B. Platelet receptors for the complement component C1q: implications for hemostasis and thrombosis. Immunbiology 1998;199:239-249.
13. 13. Peerschke EIB, Reid KBM, Ghebrehiwet B, Identification of a novel 33-kDa C1q binding site on human blood platelets. J Immunol 1994;52:5896-5901.
14. 14. Wolf P. The nature and significance of platelet products in human plasma. Br J Haematol 1967;13:269-288.
15. 15. George JN, et al. Platelet surface glycoproteins. Studies on resting and activated platelets and platelet membrane microparticles in normal subjects, and observation in individuals during adult respiratory distress syndrome and cardiac surgery. J Clin Invest 1986;78:340-348.
16. 16. Holme PA, Roger M, Solum NO, Brosstad F, Larsen AM, Hovig T. Glycoprotein IIb-IIIa on platelet-derived microparticles, and micropartide structures studied by electron microscopy, confocal laser microscopy and crossed radio-immunoelectrophoresis. Platelets 1996;7:207-214.
17. 17. Gilbert GE, Sims PJ, Wiedmer T, Furie B, Furie BC, Shattil SJ. Platelet derived microparticles express high affinity receptors for factor VIII. J Biol Chem 1991;266:17261-17268.
18. 18. Sims PJ, Faioni EM, Wiedmer T, Shattil SJ. Complement proteins C5b-9 cause release of membrane vesicles from the platelet surface that are enriched in the membrane receptor for coagulation factor Va and express prothrombinase activity. J Biol Chem 1988;263:18205-18212.
19. 19. Tans G, Rosing J, Thomassen MC, Heeb MJ, Zwaal RF, Griffin JH. Comparison of anticoagulant and procoagulant activities of stimulated platelets and platelet-derived microparticles. Blood 1991;77:2641-2648.
20. 20. Dahlbaeck B, Wiedmer T, Sims PJ. Binding of anticoagulant vitamin K-dependent protein S to platelet-derived microparticles. Biochem 1992;31:12769-12777.
21. 21. Mallat Z, et al. Elevated levels of shed membrane microparticles with procoagulant potential in the peripheral blood of patients with acute coronary syndromes. Circulation 2000;101:841-843.
22. 22. Sims PJ, Wiedmer T, Esmon CT, Weiss HJ, Shattil SJ. Assembly of the platelet prothrombinase complex is linked to vesiculation of the platelet membrane. Studies in Scott syndrome: an isolated defect in platelet procoagulant activity. J Biol Chem 1989;264:17049-17057.
23. 23. Wiedmer T, Shattil SJ, Cunningham M, Sims PJ. Role of calcium and calpain in complement-induced vesiculation of the platelet plasma membrane and in exposure of the platelet factor Va receptor. Biochemistry 1990;29:623-632.
24. 24. Holme PA, Solum NO, Brosstad F, Egberg N, Lindahl TL. Stimulated Glanzmann's thrombasthenia platelets produce microvesicles. Microvesiculation correlates better to exposure of procoagulant surface than to activation of GPIIb-IIIa. Thromb Haemost 1995;74:1533-1540.
25. 25. Miyazaki Y, et al. High shear stress can initiate both platelet aggregation and shedding of procoagulant containing microparticle. Blood 1996;88:3456-3466.
26. 26. George JN, Thoi LL, McManus LM, Reimann TA. Isolation of human platelet membrane microparticles from plasma and serum. Blood 1982;60:834-840.
27. 27. Holme PA, Solum NO, Brosstad F, Pedersen T, Levine M. Microvesicles bind soluble fibrinogen, adhere to immobilized fibrinogen and coaggregate with platelets. Thromb Haemost 1998;79:389-394.
28. 28. Kaplan KL. Platelet granule proteins: localization and secretion. Immunologic reactions of platelets. In: Gordon JL, ed. Platelets in biology and pathology. Vol 2 New York: North Holland; 1981. p. 77-90.
29. 29. Jiang J, Zhang Y, Krainer AR, Xu R-M. Crystal structure of human p32, a doughnut shaped acidic mitochondrial matrix protein. Proc Natl Acad Sci USA 1999;96:3572-3577.
30. 30. Ghebrehiwet B, Peerschke EIB. Structure and function of gC1qR: a multiligand binding cellular protein. Immunobiology 1998;199:225-238.
31. 31. Joseph K, Ghebrehiwet B, Peerschke EIB, Reid KBM, Kaplan A. Identification of the zinc-dependent endothelial cell binding protein for high molecular weight kininogen and factor XII: identity with the receptor which binds to the globular "heads" of C1q (gC1qR). Proc Natl Acad Sci USA 1996;93:8552-8557.
32. 32. Peerschke EIB, Jesty J, Reid KBM, Ghebrehiwet B. The soluble recombinant form of a binding protein/receptor for the globular domain of C1q (gC1qR) enhances blood coagulation. Blood Coagul Fibrinolysis 1998;9:29-37.
33. 33. Cazenave JP, Assimeh SN, Painter RH, Packham MA, Mustard JF. C1q inhibition of the interaction of collagen with human platelets. J Immunol 1976;116:162-163.
34. 34. Csako G, Suba EA. A physiologic regulator of collagen-induced platelet aggregation: inhibition by C1q. Thromb Haemost 1981;45:110-115.
35. 35. Wautier JL, Souchon L, Reid KBM, Peltier AP, Caen JP. Studies on the mode of reaction of the first component of complement with platelets: interaction between collagen-like portion of C1q and platelets. Immunochemistry 1977;14:763-766.
36. 36. Tiffnay ML, Penner JA. Effect of complement on collagen-induced platelet aggregation. J Lab Clin Med 1980;96:796-802.
37. 37. Peerschke EIB, Reid KBM, Ghebrehiwet B. Platelet activation by C1q results in the induction of α IIb/β 3 integrins (GPIIb-IIIa) and the expression of P-selectin and procoagulant activity. J Exp Med 1993;178:579-587.
38. 38. Ghebrehiwet B, et al. Identification of functional domains on gC1q-R, a cell surface protein which binds to the globular "heads" of C1q, using monoclonal antibodies and synthetic peptides. Hybridoma 1996;15:333-342.
39. 39. Schweitzer KM, et al. Characterization of a newly established human bone marrow endothelial cell line: distinct adhesive properties for hematopoietic progenitors compared with human umbilical vein endothelial cells. Lab Invest 1997;76:25-36.
40. 40. Yeaman MR, Norman DC, Bayer AS. Platelet microbicidal protein enhances antibiotic-induced killing of and post antibiotic effect in Staphylococcus aureus. Antimicrob Agents Chemother 1992;36:1665-1670.
41. 41. Nguyen T, Ghebrehiwet B, Peerschke EIB. Staphylococcus aureus protein A recognizes platelet gC1qR/p33: a novel mechanism for staphylococcal interactions with platelets. Infect Immun 2000;68:2061-2068.
42. 42. Archer GL. Staphylococcus aureus: a well armed pathogen. Clin Infect Dis 1998;26:1179-1181.
43. 43. Herrmann M, Hartleib J, Kehrel B, Montgomery RR, Sixma JJ, Peters G. Interaction of von Willebrand factor with Staphylococcus aureus. J Infect Dis 1997;176:984-991.
44. 44. Deisenhofer J. Crystallographic refinement and atomic models of human Fc fragments and its complex with fragment B of protein A from Staphylococcus aureus at 2.9 - and 2.8 Å resolution. Biochemistry 1981;20:2361-2370.
45. 45. Jansson B, Uhlen M, Nygren PA. All individual domains of staphylococcal protein A show Fab binding. FEMS Immunol Med Microbiol 1998;20:69-78.
46. 46. Langone JJ. Staphylococcus aureus and related immunoglobulin receptors produced by streptococci and pneumococci. Adv Immunol 1982;32:157-252.
47. 47. Harboe M, Foelling I. Recognition of two distinct groups of human IgM and IgA based on different binding to staphylococci. Scand J Immunol 1974;3:471-482.
48. 2 protein A epsilon interactions. Scand J Immunol 1981;13:343-352.
49. 49. Romagnani S, et al. Demonstration on protein A of two distinct immunoglobulin binding sites and their role in the mitogenic activity of Staphylococcus aureus Cowan I on human B cells. J Immunol 1982;129:596-602.
50. 50. Patel PC, Stefanescu-Soare I, Menezes J. Staphylococcal protein A enhances natural killing activity against lymphoid tumor cell lines. Int J Cancer 1981;28:277-284.
51. 51. Ringden O. Induction of immunoglobulin secretion by protein A from Staphylococcus aureus in human blood and bone marrow B cells. Scand J Immunol 1985;22:17-26.
52. 52. Stalenheim G, Gotze O, Cooper NR, Sjoquist J, Muller-Eberhard HJ. Consumption of human complement components by complexes of IgG with protein A of Staphylococcus aureus. Immunochemistry 1973;10:501-507.
53. 53. Fosgren A, Ghetie V, Lindmar R, Sjoquist J. Protein A and its exploitation. In: Easmon CSF, Adlam C, eds. Staphylococci and staphylococcal infections. Vol 2. London: Academic Press, Inc (London) Ltd; 1983. p. 429-478.
54. 54. Sullam PM. Host-pathogen interactions in the development of bacterial endocarditis. Curr Opin Infect Dis 1994;7:304-309.
55. 55. Braun L, Ghebrehiwet B, Cossart P, gC1qR, the receptor of C1q, acts as a receptor for InlB, an invasion protein of Listeria monocytogenes. EMBO J 2000;19:1458-1466.
56. 56. Dedio J, Muller-Esterl W. Kininogen binding protein p33/gC1qR is localized in the vesicular fraction of endothelial cells. FEBS Lett 1996;399:255-258.
57. 57. Van den Berg RH, et al. Intracellular localization of the human receptor for the globular domains of C1q. J Immunol 1997;158:3909-3916.